ImmuneBridge Inc. — Form D
ImmuneBridge Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-10. The offering totals $14.2M, of which $10.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-01-10
- Form: D
- Accession: 0001960306-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $14.2M
- Amount sold: $10.2M
- Remaining: $4.0M
- Investors: 15
- Date of first sale: 2022-12-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-470133
Issuer
- Name: ImmuneBridge Inc.
- CIK: 0001960306
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 2122 BRYANT ST, SAN FRANCISCO, CA, 94110
- Phone: 415-527-5634
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Gregory A Bonfiglio | Director | San Francisco, CA |
| Alicia Kim Jackson | Director | San Francisco, CA |
| Dylan Kim Morris | Director | San Francisco, CA |
| Peretz Partensky | Director | San Francisco, CA |
| Mary Kim Warren | Director | San Francisco, CA |
| Cheryl Kim Zimberlin | Director | San Francisco, CA |
| Peretz Partensky | Executive Officer | San Francisco, CA |
| Dylan Alexander Morris | Director | New York, NY |
| Nadiya Alexander Ishnazarova | Director | Amsterdam, P7 |
| Omri Alexander Amirav-Drory | Director | San Francisco, CA |
| Alicia Alexander Jackson | Director | San Francisco, CA |
| Stuart Alexander Jacobson | Director | San Francisco, CA |
| Stuart Alexander Jacobson | Executive Officer | San Francisco, CA |
| Thomas Alexander Farrell | Director | San Francisco, CA |
Other filings by this issuer (1)
More